A Study of Telitacicept in Lupus Nephritis

Clinical trial NCT05680480 · RECRUITING

Trial details

NCT number: NCT05680480
Sponsor: RemeGen Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2023-04-17
Primary completion: 2025-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.